Mark Sorin

1.4k total citations · 1 hit paper
19 papers, 237 citations indexed

About

Mark Sorin is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Mark Sorin has authored 19 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Physiology. Recurrent topics in Mark Sorin's work include Immune cells in cancer (3 papers), Asthma and respiratory diseases (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Mark Sorin is often cited by papers focused on Immune cells in cancer (3 papers), Asthma and respiratory diseases (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Mark Sorin collaborates with scholars based in Canada, United States and Slovenia. Mark Sorin's co-authors include Logan A. Walsh, Jonathan Spicer, Jérémie Richard, Rahul Suresh, Jasmyn E. A. Cunningham, Kayla Williams, Connor Prosty, J. Adam Carter, Pierre Fiset and Trafford Crump and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Infectious Diseases.

In The Last Decade

Mark Sorin

17 papers receiving 235 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Chemoimmunotherapy for NSCLC

2024 89 citations Mark Sorin, Connor Prosty et al. JAMA Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Sorin Canada	7	95	61	54	39	25	19	237
Mufiza Farid‐Kapadia Canada	7	95 1.0×	49 0.8×	39 0.7×	38 1.0×	7 0.3×	11	226
Alice Bessey United Kingdom	9	30 0.3×	37 0.6×	77 1.4×	34 0.9×	39 1.6×	12	327
Mounica Vallurupalli United States	9	85 0.9×	71 1.2×	88 1.6×	105 2.7×	113 4.5×	14	515
Michael Richardson United States	10	77 0.8×	53 0.9×	35 0.6×	23 0.6×	16 0.6×	37	296
Till Kaltofen Germany	10	68 0.7×	62 1.0×	48 0.9×	100 2.6×	13 0.5×	26	292
Susheel K. Khetarpal United States	7	104 1.1×	70 1.1×	21 0.4×	140 3.6×	27 1.1×	15	265
Arielle Sloan United States	8	57 0.6×	51 0.8×	17 0.3×	70 1.8×	19 0.8×	21	306
Claire E.P. Smith United States	7	111 1.2×	44 0.7×	16 0.3×	30 0.8×	28 1.1×	14	305
Celia Grosskreutz United States	8	128 1.3×	31 0.5×	125 2.3×	21 0.5×	39 1.6×	12	358
Alex Beny Israel	7	102 1.1×	42 0.7×	14 0.3×	29 0.7×	71 2.8×	12	243

Countries citing papers authored by Mark Sorin

Since Specialization

Citations

This map shows the geographic impact of Mark Sorin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sorin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sorin more than expected).

Fields of papers citing papers by Mark Sorin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sorin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sorin. The network helps show where Mark Sorin may publish in the future.

Co-authorship network of co-authors of Mark Sorin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sorin. A scholar is included among the top collaborators of Mark Sorin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sorin. Mark Sorin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dankner, Matthew, Mark Sorin, Jamie Magrill, et al.. (2025). Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis. Current Oncology. 32(11). 624–624.

Desharnais, Lysanne, Mark Sorin, Morteza Rezanejad, et al.. (2025). Spatially mapping the tumour immune microenvironments of non-small cell lung cancer. Nature Communications. 16(1). 1345–1345. 9 indexed citations

Dankner, Matthew, Joan Miguel Romero, Jamie Magrill, et al.. (2025). Patient-derived xenografts (PDX) versus patient-derived organoids (PDO) as predictors of clinical response to anti-cancer therapies.. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations

Prosty, Connor, et al.. (2024). Revisiting the Evidence Base That Informs the Use of Adjunctive Therapy for Enterococcus faecalis Endocarditis: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases. 79(5). 1162–1171.

Sorin, Mark, Connor Prosty, Matthew Dankner, et al.. (2024). Neoadjuvant Chemoimmunotherapy for NSCLC. JAMA Oncology. 10(5). 621–621. 89 indexed citations breakdown →

Doré, Samuel, Mark Sorin, Sheri A. C. McDowell, et al.. (2024). Exploring the prognostic significance of arm-level copy number alterations in triple-negative breast cancer. Oncogene. 43(26). 2015–2024. 1 indexed citations

Prosty, Connor, et al.. (2024). Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials. Clinical Microbiology and Infection. 30(7). 866–876. 6 indexed citations

Prosty, Connor, Alex Nguyen, Mark Sorin, et al.. (2023). Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTs. Blood Advances. 8(4). 857–866. 6 indexed citations

Milette, Simon, Roni Rayes, Valérie Breton, et al.. (2023). 76P Circadian control of neutrophil extracellular trap formation temporally regulates metastatic lung cancer progression. ESMO Open. 8(1). 101886–101886. 2 indexed citations

10.

Sorin, Mark, Elham Karimi, Morteza Rezanejad, et al.. (2023). Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity. Journal for ImmunoTherapy of Cancer. 11(2). e005545–e005545. 33 indexed citations

11.

Romero, Joan Miguel, Mark Sorin, Matthew Dankner, et al.. (2023). Gender Disparities in Academic Outcomes Among Graduates of a Canadian MD-PhD Program. Clinical and investigative medicine. 46(1). E4–E14. 1 indexed citations

12.

Sorin, Mark, Caroline Huynh, Roni Rayes, et al.. (2022). Neoadjuvant Targeted Therapy in Non–Small Cell Lung Cancer and Its Impact on Surgical Outcomes. Annals of Thoracic Surgery Short Reports. 1(1). 102–106. 1 indexed citations

13.

Richard, Jérémie, Rahul Suresh, J. Adam Carter, et al.. (2022). Scoping review to evaluate the effects of peer support on the mental health of young adults. BMJ Open. 12(8). e061336–e061336. 55 indexed citations

14.

Traboulsi, Hussein, Angela Rico de Souza, Benoît Allard, et al.. (2021). Differential Regulation of the Asthmatic Phenotype by the Aryl Hydrocarbon Receptor. Frontiers in Physiology. 12. 720196–720196. 5 indexed citations

15.

Sorin, Mark, David Watkins, Brian M. Gilfix, & David S. Rosenblatt. (2021). Methionine dependence in tumor cells: The potential role of cobalamin and MMACHC. Molecular Genetics and Metabolism. 132(3). 155–161. 10 indexed citations

16.

Bryan, Charles S, Jonathan Kopel, & Mark Sorin. (2021). Ira Remsen, Osler, the Flexner Report, and the full-time plan. Baylor University Medical Center Proceedings. 34(4). 532–536. 2 indexed citations

17.

Sorin, Mark, et al.. (2020). Cancer patient perspectives during the COVID-19 pandemic: A thematic analysis of cancer blog posts. Patient Experience Journal. 7(3). 31–43. 6 indexed citations

18.

Mukherjee, Manali, Mark Sorin, Katherine Radford, et al.. (2019). Sputum autoantibody-mediated macrophage dysfunction in severe eosinophilic asthmatics with recurrent infections. Journal of Allergy and Clinical Immunology. 143(2). AB189–AB189. 4 indexed citations

19.

Sorin, Mark, Eduardo L. Franco, & Amélie Quesnel‐Vallée. (2019). Inter- and Intraprovincial Inequities in Public Coverage of Cancer Drug Programs across Canada: A Plea for the Establishment of a Pan-Canadian Pharmacare Program. Current Oncology. 26(4). 266–269. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact